About evitria
evitria is a company based in Schlieren (Switzerland) founded in 2010 was acquired by Atlas Antibodies in July 2021.. evitria offers products and services including Recombinant Antibodies, Afucosylated Antibodies, Bispecific Antibodies, Fc-silenced Antibodies, and Other Proteins. evitria operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Schlieren, Switzerland
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Evitria Ag
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Atlas Antibodies
& 2 more
-
Employee Count
Employee Count
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of evitria
evitria offers a comprehensive portfolio of products and services, including Recombinant Antibodies, Afucosylated Antibodies, Bispecific Antibodies, Fc-silenced Antibodies, and Other Proteins. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Service for expressing antibodies in CHO cells with fast turnaround.
Antibodies enhanced for increased ADCC activity in therapeutics.
Antibodies targeting multiple antigens for complex applications.
Antibodies designed to reduce effector functions effectively.
Service for producing various secreted proteins as needed.
Funding Insights of evitria
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in evitria
evitria has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Atlas Antibodies, SHS Capital and Afinum. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare-focused private equity investments are managed by SHS Capital.
|
Founded Year | Domain | Location | |
|
Private equity investments are managed by Afinum for mid-sized companies.
|
Founded Year | Domain | Location | |
|
Antibodies and research reagents targeting human proteins are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by evitria
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - evitria
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Evitria Comparisons
Competitors of evitria
evitria operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Evitria
Frequently Asked Questions about evitria
When was evitria founded?
evitria was founded in 2010.
Where is evitria located?
evitria is headquartered in Schlieren, Switzerland. It is registered at Schlieren, Zurich, Switzerland.
Who is the current CEO of evitria?
Christian Eberle is the current CEO of evitria.
What does evitria do?
Founded in 2010, evitria operates as a contract research organization based in Schlieren, Switzerland. Focus is placed on transient protein expression using CHO cells, with services extended to recombinant antibodies, afucosylated antibodies, and other proteins. Operations support biotech and pharmaceutical sectors through these specialized expression capabilities, enabling research and development in antibody and protein therapeutics.
Who are the top competitors of evitria?
evitria's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does evitria offer?
evitria offers Recombinant Antibodies, Afucosylated Antibodies, Bispecific Antibodies, Fc-silenced Antibodies, and Other Proteins.
Who are evitria's investors?
evitria has 3 investors. Key investors include Atlas Antibodies, SHS Capital, and Afinum.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.